CytomX Therapeutics, Inc. (CTMX)
5.67
+0.43
(+8.21%)
USD |
NASDAQ |
Feb 06, 16:00
5.79
+0.12
(+2.12%)
After-Hours: 20:00
CytomX Therapeutics SG&A Expense (TTM) : 28.10M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| REGENXBIO, Inc. | 80.53M |
| ACADIA Pharmaceuticals, Inc. | 523.36M |
| Alnylam Pharmaceuticals, Inc. | 1.181B |
| Savara, Inc. | 37.38M |
| BioMarin Pharmaceutical, Inc. | 973.41M |